The public float for IBO is 5.16M, and currently, short sellers hold a 0.17% ratio of that float. The average trading volume of IBO on March 31, 2025 was 3.14M shares.
IBO) stock’s latest price update
The stock of Impact BioMedical Inc (AMEX: IBO) has decreased by -33.33 when compared to last closing price of 2.28.Despite this, the company has seen a loss of -69.35% in its stock price over the last five trading days. globenewswire.com reported 2025-03-21 that HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no material development in its business affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action regarding its share price.
IBO’s Market Performance
Impact BioMedical Inc (IBO) has experienced a -69.35% fall in stock performance for the past week, with a -1.30% drop in the past month, and a 6.29% rise in the past quarter. The volatility ratio for the week is 49.86%, and the volatility levels for the past 30 days are at 56.31% for IBO. The simple moving average for the past 20 days is -3.47% for IBO’s stock, with a -22.16% simple moving average for the past 200 days.
IBO Trading at -13.03% from the 50-Day Moving Average
After a stumble in the market that brought IBO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.36% of loss for the given period.
Volatility was left at 56.31%, however, over the last 30 days, the volatility rate increased by 49.86%. Over the last 50 days, in opposition, the stock is trading unchanged at present.
During the last 5 trading sessions, IBO remain unchanged, which changed the moving average for the period of 200-days by +2.64% in comparison to the 20-day moving average, which settled at $24.84. In addition, Impact BioMedical Inc saw 4.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IBO starting from DSS, INC., who sale 499,800 shares at the price of $3.30 back on Mar 21 ’25. After this action, DSS, INC. now owns 0 shares of Impact BioMedical Inc, valued at $1,649,540 using the latest closing price.
DSS, INC., the 10% Owner of Impact BioMedical Inc, sale 58,139 shares at $3.13 during a trade that took place back on Mar 26 ’25, which means that DSS, INC. is holding 1,099,481 shares at $182,134 based on the most recent closing price.
Stock Fundamentals for IBO
Current profitability levels for the company are sitting at:
- 0.46 for the present operating margin
- 1.0 for the gross margin
The net margin for Impact BioMedical Inc stands at -9.8. The total capital return value is set at 0.09. Equity return is now at value -167.65, with -76.13 for asset returns.
Based on Impact BioMedical Inc (IBO), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -2.49. The debt to equity ratio resting at 0.44. The interest coverage ratio of the stock is 7.34.
When we switch over and look at the enterprise to sales, we see a ratio of 7.36. The receivables turnover for the company is 4.64for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.25.
Conclusion
To put it simply, Impact BioMedical Inc (IBO) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
